Interests: Cell fate decisions and epigenetic buffering; tissue specific DNA architecture based vulnerabilities to cancer Eli joined the lab in 2020 and is currently studying the role of mitochondrial MDM2 in liposarcoma, both from a wet lab and computational perspective.
Gabriel Griffin earned his undergraduate and medical degrees at Duke University and completed his residency and fellowship training in hematopathology at the Brigham and Women’s Hospital. In his post-doctoral research, Gabe is studying the epigenetic regulation of immune sensitivity in cancer. Gabe is a recipient of the Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation.
